8-K/A: Electromedical Technologies Increases Authorized Shares After Initial Amendment Cancellation

Electromedical Technologies increased its authorized shares to five billion, one million, and one, after canceling a previous amendment to increase the total number of authorized shares to three billion, one million, and one.

Summary

• Electromedical Technologies initially planned to increase its authorized shares to 3,001,001.
• This initial amendment was approved on July 18, 2024.
• However, on August 6, 2024, the Board of Directors and a majority of shareholders voted to cancel the July 18th amendment.
• Instead, they approved a new amendment to increase the total authorized shares to 5,001,001.
• This new total includes 5,000,000,000 common shares, 1,000,000 Series A preferred shares, and 1 Series B preferred share.
• All shares have a par value of $0.00001 per share.
• The Certificate of Amendment is being processed by the Delaware Secretary of State and will be effective upon completion of the filing.

Sentiment

Score: 6

Explanation: The document describes a routine corporate action, which is neither particularly positive nor negative. The increase in authorized shares could be seen as a positive for future growth, but also carries the risk of dilution.

Risks

• The increase in authorized shares could potentially dilute existing shareholders' ownership if new shares are issued.

Future Outlook

The company is awaiting the Delaware Secretary of State to process the Certificate of Amendment, which will be effective upon completion of the filing.

Management Comments

• Matthew Wolfson, Chief Executive Officer, signed the report on behalf of the company.

Industry Context

Changes to authorized share capital are a common corporate action, often used to facilitate future fundraising, acquisitions, or stock-based compensation plans. This action is not unusual for a company of this size.

Comparison to Industry Standards

• Many companies in the technology and medical device sectors adjust their authorized share capital as part of their growth strategy.
• The specific increase from 3,001,001 to 5,001,001 shares is not directly comparable without knowing the company's specific needs and future plans.
• Companies like Medtronic or Boston Scientific, which are much larger, have significantly higher authorized share counts due to their scale and history.

Stakeholder Impact

• Shareholders may experience dilution if new shares are issued.
• The increase in authorized shares could provide the company with more flexibility for future growth and strategic initiatives.

Next Steps

• The company is awaiting the Delaware Secretary of State to process the Certificate of Amendment.
• The amendment will be effective upon completion of the filing.

Key Dates

Keywords

authorized shares, share increase, certificate of amendment, common stock, preferred stock, corporate governance, shareholder approval